WEX Pharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15784
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

WEX Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

WEX Pharmaceuticals Inc (WEX), a subsidiary of CK Life Sciences Int’l., (Holdings) Inc., is a clinical stage biotechnology company that focuses on the discovery, development, manufacture and commercialization of drugs for pain management. The company develops a new class of non-opioid analgesics utilizing its proprietary platform technology TTX (Tetrodotoxin or TTX). TTX is a non-peptide neurotoxin, non-addictive alternative to opioids, and a sodium channel blocker. WEX’s clinical candidates include TEC-006 and TTX-CINP-201. TEC-006 is being studied for the treatment of moderate to severe cancer related pain and TTX-CINP-201 is being developed for moderate to severe neuropathic pain caused by chemotherapy in patients with cancer. WEX is headquartered in Vancouver, British Columbia, Canada.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
WEX Pharmaceuticals Inc – Key Facts
WEX Pharmaceuticals Inc – Key Employees
WEX Pharmaceuticals Inc – Key Employee Biographies
WEX Pharmaceuticals Inc – Major Products and Services
WEX Pharmaceuticals Inc – History
WEX Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
WEX Pharmaceuticals Inc – Business Description
WEX Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
WEX Pharmaceuticals Inc – Strengths
WEX Pharmaceuticals Inc – Weaknesses
WEX Pharmaceuticals Inc – Opportunities
WEX Pharmaceuticals Inc – Threats
WEX Pharmaceuticals Inc – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
WEX Pharmaceuticals Inc, Key Facts
WEX Pharmaceuticals Inc, Key Employees
WEX Pharmaceuticals Inc, Key Employee Biographies
WEX Pharmaceuticals Inc, Major Products and Services
WEX Pharmaceuticals Inc, History
WEX Pharmaceuticals Inc, Key Competitors

★海外企業調査レポート[WEX Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Celesio AG:企業のM&A・事業提携・投資動向
    Celesio AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celesio AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • CMA CGM SA:企業のM&A・事業提携・投資動向
    CMA CGM SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CMA CGM SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Crystal Pharmatech Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Crystal Pharmatech Co Ltd (Crystal Pharmatech) is a contract research organization that conducts research on engineering and materials science for drug development. The organization offers pharmaceutical solid-state research services such as solid form screening and selection, single crystal …
  • Sigdo Koppers SA:企業の戦略・SWOT・財務情報
    Sigdo Koppers SA - Strategy, SWOT and Corporate Finance Report Summary Sigdo Koppers SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Magnitogorsk Iron & Steel Works:企業の戦略・SWOT・財務情報
    Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hindustan Unilever Limited:戦略・SWOT・企業財務分析
    Hindustan Unilever Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Unilever Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cosmos Insurance Public Company Ltd
    Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • GSI Technology, Inc. (GSIT):企業の財務・戦略的SWOT分析
    GSI Technology, Inc. (GSIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Baker Hughes, a GE Co LLC:企業の戦略的SWOT分析
    Baker Hughes, a GE Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • DCC plc (DCC):企業の財務・戦略的SWOT分析
    DCC plc (DCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Sanofi (SAN)-医療機器分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on researching, developing, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; huma …
  • Guess Inc (GES):企業の財務・戦略的SWOT分析
    Guess Inc (GES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Consolidated Edison Company of New York, Inc.:発電所・企業SWOT分析
    Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • DRDGOLD Ltd:企業の戦略・SWOT・財務情報
    DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report Summary DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • Interface Biologics Inc:製品パイプライン分析
    Summary Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies includ …
  • Covagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Covagen AG (Covagen), a subsidiary of Cilag GmbH International is a biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology. The company’s pipeline products include COVA 322, a bispecific anti-tumor necrosis factor alpha …
  • FirstCash Inc:企業の戦略・SWOT・財務情報
    FirstCash Inc - Strategy, SWOT and Corporate Finance Report Summary FirstCash Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gamma Solutions SL:電力:M&Aディール及び事業提携情報
    Summary Gamma Solutions SL (Gamma Solutions) is an engineering and consulting company that operates through energy, telecommunication, mobile and IT, and research and development divisions. The company offers products such as gamma start city monitoring system, photovoltaic rooftop monitoring system …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆